Armistice Capital, LLC's Form 4 filing
Kiora Pharmaceuticals Inc (KPRX) · filed Jul 29, 2021
- Accession no.
- 0000899243-21-030722
- Filed
- Jul 29, 2021, 7:59 PM ET
- Trade date
- Jul 27-29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $14.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Armistice Capital, LLCCIK 0001601086 | Director, 10% Owner |
| Armistice Capital Master Fund Ltd.CIK 0001633584 | Director, 10% Owner |
| Boyd StevenCIK 0001706140 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | CConversionAcquired | +852,500 | $4.80 | +$4,092,000 | 4,199,101 | Indirect | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −73,101 | $7.06 | −$516,107.68 | 4,126,000 | Indirect | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −461,797 | $6.45 | −$2,980,853.46 | 3,664,203 | Indirect | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −729,114 | $5.44 | −$3,966,161.43 | 2,935,089 | Indirect | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −532,069 | $4.59 | −$2,440,972.95 | 2,403,020 | Indirect | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −581,614 | $3.80 | −$2,209,551.59 | 1,821,406 | Indirect | |
| Jul 28, 2021 | Common Stock | SSaleDisposed | −375,443 | $3.28 | −$1,232,616.91 | 1,445,963 | Indirect | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −400,000 | $3.00 | −$1,200,000 | 1,045,963 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | CConversionDisposed | −852,500 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.